The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Procoagulant Activity in Hemostasis and Thrombosis: Virchow's Triad Revisited
Open accessAbstract
Virchow's triad is traditionally invoked to explain pathophysiologic mechanisms leading to thrombosis, alleging concerted roles for abnormalities in blood composition, vessel wall components, and blood flow in the development of arterial and venous thrombosis. Given the tissue-specific bleeding observed in hemophilia patients, it may be instructive to consider the principles of Virchow's triad when investigating mechanisms operant in hemostatic disorders as well. Blood composition (the function of circulating blood cells and plasma proteins) is the most well studied component of the triad. For example, increased levels of plasma procoagulant proteins such as prothrombin and fibrinogen are established risk factors for thrombosis, whereas deficiencies in plasma factors VIII and IX result in bleeding (hemophilia A and B, respectively). Vessel wall (cellular) components contribute adhesion molecules that recruit circulating leukocytes and platelets to sites of vascular damage, tissue factor, which provides a procoagulant signal of vascular breach, and a surface upon which coagulation complexes are assembled. Blood flow is often characterized by 2 key variables: shear rate and shear stress. Shear rate affects several aspects of coagulation, including transport rates of platelets and plasma proteins to and from the injury site, platelet activation, and the kinetics of fibrin monomer formation and polymerization. Shear stress modulates adhesion rates of platelets and expression of adhesion molecules and procoagulant activity on endothelial cells lining the blood vessels. That no one abnormality in any component of Virchow's triad fully predicts coagulopathy a priori suggests coagulopathies are complex, multifactorial, and interactive. In this review, we focus on contributions of blood composition, vascular cells, and blood flow to hemostasis and thrombosis, and suggest that cross-talk among the 3 components of Virchow's triad is necessary for hemostasis and determines propensity for thrombosis or bleeding. Investigative models that permit interplay among these components are necessary to understand the operant pathophysiology, and effectively treat and prevent thrombotic and bleeding disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,646
Deficiency of protein C in congenital thrombotic disease.
Griffin, J. H., Evatt, B., Zimmerman, T. S., Kleiss, A. J., & Wideman, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110385 · Cited by 1,250
Lindahl, B., Toss, H., Siegbahn, A., Venge, P., & Wallentin, L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431602 · Cited by 1,224
Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology
Davies, P. F. (2009) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1397 · Cited by 1,209
The role of shear stress in the pathogenesis of atherosclerosis
Cunningham, K. S., & Gotlieb, A. I. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700215 · Cited by 1,151
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,067
Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis
Ageno, W., Becattini, C., Brighton, T., Selby, R., & Kamphuisen, P. W. (2008) · Circulation · doi:10.1161/circulationaha.107.709204 · Cited by 974
Yarnell, J. W., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., Whitehead, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 916
Fibrinogen and Risk of Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 886
A shear gradient–dependent platelet aggregation mechanism drives thrombus formation
Nesbitt, W. S., Westein, E., Tovar-Lopez, F. J., Tolouei, E., Mitchell, A., Fu, J., Carberry, J., Fouras, A., & Jackson, S. P. (2009) · Nature Medicine · doi:10.1038/nm.1955 · Cited by 862
Microparticles in Hemostasis and Thrombosis
Owens, A. P., & Mackman, N. (2011) · Circulation Research · doi:10.1161/circresaha.110.233056 · Cited by 835
Factor XI Activation in a Revised Model of Blood Coagulation
Gailani, D., & Broze, G. J. (1991) · Science · doi:10.1126/science.1652157 · Cited by 775
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
Kyrle, P. A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K., & Eichinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430702 · Cited by 763
Bolton-Maggs, P. H., & Pasi, K. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13405-8 · Cited by 763
Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., Croce, K., Furie, B. C., & Furie, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021868 · Cited by 752
Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2
Parmar, K. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24787 · Cited by 701
Virchow and his triad: a question of attribution
Bagot, C. N., & Arya, R. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07323.x · Cited by 655
Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques
Toschi, V., Gallo, R., Lettino, M., Fallon, J. T., Gertz, S. D., Ferna´ndez-Ortiz, A., Chesebro, J. H., Badimon, L., Nemerson, Y., Fuster, V., et al. (1997) · Circulation · doi:10.1161/01.cir.95.3.594 · Cited by 603
Sims, P. J., Wiedmer, T., Esmon, C. T., Weiss, H. J., & Shattil, S. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71457-9 · Cited by 596
Fibrinogen and risk of cardiovascular disease
Nguyen, V. (1988) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(88)80530-4 · Cited by 593
Fluid Mechanics of Vascular Systems, Diseases, and Thrombosis
Wootton, D. M., & Ku, D. N. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.299 · Cited by 559
Shet, A. S., Aras, O., Gupta, K., Hass, M. J., Rausch, D. J., Saba, N., Koopmeiners, L., Key, N. S., & Hebbel, R. P. (2003) · Blood · doi:10.1182/blood-2003-03-0693 · Cited by 539
Structural Origins of Fibrin Clot Rheology
Ryan, E. A., Mockros, L. F., Weisel, J. W., & Lorand, L. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77113-4 · Cited by 537
Cellular Mechanisms Underlying the Formation of Circulating Microparticles
Morel, O., Jesel, L., Freyssinet, J.-M., & Toti, F. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.200956 · Cited by 526
Toss, H., Lindahl, B., Siegbahn, A., Wallentin, L., & Group, F. T. F. S. (1997) · Circulation · doi:10.1161/01.cir.96.12.4204 · Cited by 520
Effects of Severe Hypertension on Endothelial and Platelet Microparticles
Preston, R. A., Jy, W., Jimenez, J. J., Mauro, L. M., Horstman, L. L., Valle, M., Aime, G., & Ahn, Y. S. (2003) · Hypertension · doi:10.1161/01.hyp.0000049760.15764.2d · Cited by 499
Collet, J. P., Park, D., Lesty, C., Soria, J., Soria, C., Montalescot, G., & Weisel, J. W. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1354 · Cited by 492
Zwicker, J. I., Liebman, H. A., Neuberg, D., Lacroix, R., Bauer, K. A., Furie, B. C., & Furie, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0371 · Cited by 479
What Does It Take to Make the Perfect Clot?
Monroe, D. M., & Hoffman, M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000193624.28251.83 · Cited by 431
Biggs, R., Douglas, A. S., Macfarlane, R. G., Dacie, J. V., Pitney, W. R., Merskey, C., & O'Brien, J. R. (1952) · BMJ · doi:10.1136/bmj.2.4799.1378 · Cited by 427
A Model for the Stoichiometric Regulation of Blood Coagulation
Hockin, M. F., Jones, K. C., Everse, S. J., & Mann, K. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201173200 · Cited by 400
X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua)
Simioni, P., Tormene, D., Tognin, G., Gavasso, S., Bulato, C., Iacobelli, N. P., Finn, J. D., Spiezia, L., Radu, C., & Arruda, V. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904377 · Cited by 394
Flow Effects on Coagulation and Thrombosis
Hathcock, J. J. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000229658.76797.30 · Cited by 387
Kruppel-Like Factor 2 (KLF2) Regulates Endothelial Thrombotic Function
Lin, Z., Kumar, A., SenBanerjee, S., Staniszewski, K., Parmar, K., Vaughan, D. E., Gimbrone, M. A., Balasubramanian, V., García-Cardeña, G., & Jain, M. K. (2005) · Circulation Research · doi:10.1161/01.res.0000159707.05637.a1 · Cited by 385
Hron, G., Kollars, M., Binder, B. R., Eichinger, S., & Kyrle, P. A. (2006) · JAMA · doi:10.1001/jama.296.4.397 · Cited by 381
Kruppel-like Factor 4 Regulates Endothelial Inflammation
Hamik, A., Lin, Z., Kumar, A., Balcells, M., Sinha, S., Katz, J., Feinberg, M. W., Gerszten, R. E., Edelman, E. R., & Jain, M. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700078200 · Cited by 379
Meltzer, M. E., Lisman, T., de Groot, P. G., Meijers, J. C. M., le Cessie, S., Doggen, C. J. M., & Rosendaal, F. R. (2010) · Blood · doi:10.1182/blood-2010-02-267740 · Cited by 364
Dekker, R. J., Boon, R. A., Rondaij, M. G., Kragt, A., Volger, O. L., Elderkamp, Y. W., Meijers, J. C. M., Voorberg, J., Pannekoek, H., & Horrevoets, A. J. G. (2006) · Blood · doi:10.1182/blood-2005-08-3465 · Cited by 353
Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B
Béguin, S., Lienhart, A., Al Dieri, R., Trzeciak, C., Bordet, J., Hemker, C., Negrier, C., & Dargaud, Y. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-10-0706 · Cited by 336
Chirinos, J. A., Heresi, G. A., Velasquez, H., Jy, W., Jimenez, J. J., Ahn, E., Horstman, L. L., Soriano, A. O., Zambrano, J. P., & Ahn, Y. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.075 · Cited by 323
Reinhardt, C., von Brühl, M.-L., Manukyan, D., Grahl, L., Lorenz, M., Altmann, B., Dlugai, S., Hess, S., Konrad, I., Orschiedt, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32376 · Cited by 323
Elevated Factor VIII Levels and the Risk of Thrombosis
Kamphuisen, P. W., Eikenboom, J. C. J., & Bertina, R. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.5.731 · Cited by 316
Biró, É., Sturk-Maquelin, K. N., Vogel, G. M. T., Meuleman, D. G., Smit, M. J., Hack, C. E., Sturk, A., & Nieuwland, R. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00456.x · Cited by 314
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer
KHORANA, A. A., FRANCIS, C. W., MENZIES, K. E., WANG, J.-G., HYRIEN, O., HATHCOCK, J., MACKMAN, N., & TAUBMAN, M. B. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03156.x · Cited by 309
Kuharsky, A. L., & Fogelson, A. L. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)76085-7 · Cited by 307
The Thrombogram in Rare Inherited Coagulation Disorders: Its Relation to Clinical Bleeding
Al Dieri, R., Peyvandi, F., Santagostino, E., Giansily, M., Mannucci, P. M., Schved, J., Béguin, S., & Hemker, H. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613258 · Cited by 290
Fibrin Fibers Have Extraordinary Extensibility and Elasticity
Liu, W., Jawerth, L. M., Sparks, E. A., Falvo, M. R., Hantgan, R. R., Superfine, R., Lord, S. T., & Guthold, M. (2006) · Science · doi:10.1126/science.1127317 · Cited by 270
Kamphuisen, P., Eikenboom, J., Vos, H., Pablo, R., Sturk, A., Rosendaal, F., & Bertina, R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614553 · Cited by 259
Monocytic microparticles activate endothelial cells in an IL-1β–dependent manner
Wang, J.-G., Williams, J. C., Davis, B. K., Jacobson, K., Doerschuk, C. M., Ting, J. P.-Y., & Mackman, N. (2011) · Blood · doi:10.1182/blood-2011-01-330878 · Cited by 259
Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation
Blombäck, B., Carlsson, K., Fatah, K., Hessel, B., & Procyk, R. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90227-5 · Cited by 259
Fay, W. P., Parker, A. C., Condrey, L. R., & Shapiro, A. D. (1997) · Blood · doi:10.1182/blood.v90.1.204 · Cited by 251
Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors
Soucie, J. M. (2004) · Blood · doi:10.1182/blood-2003-05-1457 · Cited by 244
Yank, V., Tuohy, C. V., Logan, A. C., Bravata, D. M., Staudenmayer, K., Eisenhut, R., Sundaram, V., McMahon, D., Olkin, I., McDonald, K. M., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-8-201104190-00004 · Cited by 240
A model for the tissue factor pathway to thrombin. I. An empirical study.
Lawson, J. H., Kalafatis, M., Stram, S., & Mann, K. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31661-7 · Cited by 237
Badimon, J. J., Lettino, M., Toschi, V., Fuster, V., Berrozpe, M., Chesebro, J. H., & Badimon, L. (1999) · Circulation · doi:10.1161/01.cir.99.14.1780 · Cited by 228
Pabinger, I., & Schneider, B. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.6.742 · Cited by 224
Polyphosphate enhances fibrin clot structure
Smith, S. A., & Morrissey, J. H. (2008) · Blood · doi:10.1182/blood-2008-03-145755 · Cited by 214
Role of P-selectin and PSGL-1 in coagulation and thrombosis
R.Vandendries, E., Furie, B., & Furie, B. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-05-0306 · Cited by 208
Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice
Machlus, K. R., Cardenas, J. C., Church, F. C., & Wolberg, A. S. (2011) · Blood · doi:10.1182/blood-2010-11-316885 · Cited by 206
Self-citationA multiscale model of thrombus development
Xu, Z., Chen, N., Kamocka, M. M., Rosen, E. D., & Alber, M. (2008) · Journal of The Royal Society Interface · doi:10.1098/rsif.2007.1202 · Cited by 192
Microparticle-associated tissue factor activity in cancer patients with and without thrombosis
TESSELAAR, M. E. T., ROMIJN, F. P. H. T. M., VAN DER LINDEN, I. K., BERTINA, R. M., & OSANTO, S. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03504.x · Cited by 179
ALEMAN, M. M., GARDINER, C., HARRISON, P., & WOLBERG, A. S. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04488.x · Cited by 178
Self-citationWolberg, A. S., Monroe, D. M., Roberts, H. R., & Hoffman, M. (2003) · Blood · doi:10.1182/blood-2002-08-2527 · Cited by 175
Self-citationBhattacharya, R., SenBanerjee, S., Lin, Z., Mir, S., Hamik, A., Wang, P., Mukherjee, P., Mukhopadhyay, D., & Jain, M. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500200200 · Cited by 174
Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system
Allen, G. A., Wolberg, A. S., Oliver, J. A., Hoffman, M., Roberts, H. R., & Monroe, D. M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7933.2003.00617.x · Cited by 170
Self-citationGross, P. L., Furie, B. C., Merrill‐Skoloff, G., Chou, J., & Furie, B. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405193 · Cited by 166
Mechanical factors affecting hemostasis and thrombosis
Turitto, V. T., & Hall, C. L. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00157-1 · Cited by 164
Campbell, R. A., Overmyer, K. A., Selzman, C. H., Sheridan, B. C., & Wolberg, A. S. (2009) · Blood · doi:10.1182/blood-2009-06-228940 · Cited by 147
Self-citationThe role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX
He, S., Blombäck, M., Ekman, G. J., et al. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00242.x · Cited by 140
High dose factor VIIa improves clot structure and stability in a model of haemophilia B
Wolberg, A. S., Allen, G. A., Monroe, D. M., Hedner, U. K. E., Roberts, H. R., & Hoffman, M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05820.x · Cited by 138
Self-citationVlieg, A. V. H., & Rosendaal, F. R. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2003.0543b.x · Cited by 137
Neeves, K. B., Illing, D. A. R., & Diamond, S. L. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.4275 · Cited by 134
Shen, F., Kastrup, C. J., Liu, Y., & Ismagilov, R. F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.173930 · Cited by 132
Fogelson, A. L., & Tania, N. (2005) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000089930 · Cited by 128
Pressure Enhances Endothelin-1 Release From Cultured Human Endothelial Cells
Hishikawa, K., Nakaki, T., Marumo, T., et al. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.449 · Cited by 118
Valves of the deep venous system: an overlooked risk factor
Brooks, E. G., Trotman, W., Wadsworth, M. P., Taatjes, D. J., Evans, M. F., Ittleman, F. P., CALLAS, P. W., Esmon, C. T., & Bovill, E. G. (2009) · Blood · doi:10.1182/blood-2009-03-209981 · Cited by 115
Machlus, K. R., Colby, E., Wu, J. R., Koch, G. G., Key, N. S., & Wolberg, A. S. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0180 · Cited by 103
Self-citationPlatelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa
Hathcock, J. J., & Nemerson, Y. (2004) · Blood · doi:10.1182/blood-2003-12-4352 · Cited by 102
Hechler, B., Nonne, C., Eckly, A. E., Magnenat, S., Rinckel, J., Denis, C. V., Freund, M., Cazenave, J., Lanza, F., & Gachet, C. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03666.x · Cited by 95
Becattini, C., Vedovati, M. C., Ageno, W., Dentali, F., & Agnelli, G. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03777.x · Cited by 94
Cause-effect relation between hyperfibrinogenemia and vascular disease
Kerlin, B. A., Cooley, B. C., Isermann, B., Hernández, I., Sood, R., Zogg, M., Hendrickson, S. B., Mosesson, M. W., Lord, S. T., & Weiler-Guettler, H. (2003) · Blood · doi:10.1182/blood-2003-08-2886 · Cited by 94
Herbert, J., Savi, P., Laplace, M.-C., & Lalé, A. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81139-d · Cited by 91
Tissue factor around dermal vessels has bound factor VII in the absence of injury
Hoffman, M., Colina, C. M., McDonald, A. G., Arepally, G. M., Pedersen, L. G., & Monroe, D. M. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02576.x · Cited by 82
Ramacciotti, E., Hawley, A. E., Farris, D. M., Ballard, N., Wrobleski, S. K., Myers, D. D., Henke, P. K., & Wakefield, T. W. (2009) · PubMed · Cited by 81
Hawley, A. E., Farris, D. M., Ballard, N., Wrobleski, S. K., Myers, D. D., Henke, P. K., Wakefield, T. W., & Ramacciotti, E. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-09-0620 · Cited by 78
Campbell, R. A., Overmyer, K. A., Bagnell, C. R., & Wolberg, A. S. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.176008 · Cited by 77
Self-citationYong, A. S. C., Pennings, G. J., Chang, M., Hamzah, A., Chung, T., Qi, M., Brieger, D. B., Behnia, M., Krilis, S. A., Ng, M., et al. (2010) · Blood · doi:10.1182/blood-2010-04-278812 · Cited by 74
Chernysh, I. N., Nagaswami, C., & Weisel, J. W. (2011) · Blood · doi:10.1182/blood-2010-07-297671 · Cited by 69
Nair, C. H., Shah, G. A., & Dhall, D. P. (1986) · Thrombosis Research · doi:10.1016/0049-3848(86)90117-9 · Cited by 67
Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer
Kanazawa, S., Nomura, S., Kuwana, M., Muramatsu, M., Yamaguchi, K., & Fukuhara, S. (2003) · Lung Cancer · doi:10.1016/s0169-5002(02)00441-5 · Cited by 67
The Role of Thrombolysis in the Clinical Management of Deep Vein Thrombosis
Popuri, R., & Vedantham, S. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213413 · Cited by 67
Sørensen, B., Persson, E., & Ingerslev, J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06534.x · Cited by 63
Computational Approaches to Studying Thrombus Development
Xu, Z., Kamocka, M. M., Alber, M., & Rosen, E. D. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213397 · Cited by 61
Alterations of Fibrinogen Structure in Human Disease
Hoffman, M. (2008) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152508784871981 · Cited by 58
Machlus, K. R., Lin, F., & Wolberg, A. S. (2011) · Blood · doi:10.1182/blood-2011-06-362814 · Cited by 50
Self-citationMónica Acevedo, B., Pearce, G. L., Kottke‐Marchant, K., & Sprecher, D. L. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000020007.25154.62 · Cited by 47
A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia
Chen, Y., Sullivan, C., Peng, C., Shan, Y., Hu, Y., Li, D., & Li, S. (2011) · Blood · doi:10.1182/blood-2010-11-316760 · Cited by 40
A bleeding disorder characterised by isolated deficiency of platelet microvesicle generation
Castaman, G., Li, Y., & Rodeghiero, F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91259-3 · Cited by 38
A Novel Transgenic Mouse Model of Hyperfibrinogenemia
Gulledge, A. A., Rezaee, F., Verheijen, J. H., & Lord, S. T. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616079 · Cited by 37
Effects of Hyperfibrinogenemia on Vasculature of C57BL/6 Mice With and Without Atherogenic Diet
Gulledge, A. A., McShea, C., Schwartz, T. A., Koch, G. G., & Lord, S. T. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000041037.06509.c2 · Cited by 23
Dabigatran Challenges Warfarin’s Superiority for Stroke Prevention in Atrial Fibrillation
Schwartz, N. E., & Albers, G. W. (2010) · Stroke · doi:10.1161/strokeaha.110.584557 · Cited by 22
Cited by
Prosthetic Heart Valve Thrombosis
Dangas, G. D., Weitz, J. I., Giustino, G., Makkar, R., & Mehran, R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.958 · Cited by 502
Wolberg, A. S., Rosendaal, F. R., Weitz, J. I., Jaffer, I. H., Agnelli, G., Baglin, T., & Mackman, N. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.6 · Cited by 369
Self-citationJain, A., Barrile, R., van der Meer, A., Mammoto, A., Mammoto, T., De Ceunynck, K., Aisiku, O., Otieno, M., Louden, C., Hamilton, G., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.742 · Cited by 325
Neutrophil extracellular traps (NETs) - formation and implications.
Zawrotniak, M., & Rapala-Kozik, M. (2013) · Acta Biochimica Polonica · doi:10.18388/abp.2013_1983 · Cited by 274
Interference with the host haemostatic system by schistosomes
Mebius, M. M., van Genderen, P. J. J., Urbanus, R. T., Tielens, A. G. M., de Groot, P. G., & van Hellemond, J. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003781 · Cited by 83
Metadata
- Authors
- Wolberg, A. S., Aleman, M. M., Leiderman, K., & Machlus, K. R.
- Venue
- Anesthesia & Analgesia
- Published
- 2012-02
- Volume
- 114
- Issue
- 2
- Pages
- 275-285
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2034371538
- Cited by
- 312
- References
- 107
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.